Search Results 41-50 of 16136 for immunothérapie Bylaska
The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...
About this study. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment ...
The purpose of this study is to determine whether Nivolumab, in combination with brentuximab vedotin, is safe and effective in patients with certain subtypes of ...
Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas. Rochester, Minn. To investigate the efficacy of autologous Epstein-barr virus (EBV)- ...
About this study. The primary objectives of this study are to evaluate safety/tolerability and immunogenicity of IMU-201 as monotherapy and in combination ...
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
About this study. The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy ...
But, there is fast becoming a fourth option for some types of cancer: immunotherapy, which is a biological therapy where the patient's own immune system is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.